杨德龙：2026年消费板块有望从“低配”转为“标配”科技股仍是投资主线之一

Core Viewpoint - The macroeconomic recovery in China is expected in 2026, driven by policies aimed at boosting domestic demand, investment, and consumption, which will improve economic indicators and stabilize various sectors [1][2]. Economic Recovery and Investment Direction - The "three drivers" of economic growth—consumption, investment, and exports—are facing slowdowns, but policies such as trade-in programs and increased subsidies are expected to stimulate consumption [1][2]. - Infrastructure construction will be accelerated to stabilize investment growth, particularly in traditional and new infrastructure projects like data centers and charging stations [2][3]. - The consumer sector is anticipated to recover, especially in traditional consumption areas like liquor and food, as well as new consumption fields [2][4]. Capital Market Dynamics - The capital market is expected to deepen its recovery, supported by a significant amount of maturing deposits (estimated at 50 trillion yuan) that may flow into equities and bonds for better returns [3]. - The stock market has shown strong performance at the beginning of 2026, with the Shanghai Composite Index experiencing a continuous upward trend and increased trading volume [3][4]. - Various sectors, including technology, new energy, and precious metals, are expected to perform well, with a notable increase in investor confidence [3][4]. Sector-Specific Insights - The humanoid robot industry is transitioning from early development to mass production, with significant potential for commercial applications and orders in 2026 [6]. - The semiconductor industry remains a focus for policy support, with ongoing investments aimed at overcoming key technological challenges [7]. - The new energy sector, previously affected by overcapacity, is expected to see a turnaround due to government initiatives aimed at improving competition and fostering growth [8]. Long-term Trends and Strategic Assets - The competition between nations is increasingly centered around power and computing capabilities, with China holding a significant advantage in electricity generation [9]. - Precious metals like gold and silver are gaining attention as strategic assets amid global economic shifts, with potential for long-term investment despite short-term volatility [10]. - The biopharmaceutical sector is experiencing divergence, with innovative drugs showing promise for future growth, while generic drugs face challenges [10].